PROM1 and neoplasm: The combined treatment showed an improved response in terms of reduced invasion, cell growth, and the colony-forming capability of tumor cells, and also decreased the expression of different CSC markers such as aldehyde dehydrogenases (ALDH), CD166, CD44, and CD133 [50].